Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_assertion description "[The frequencies of several aberrations varied with type of therapy, eg, 5q- was more frequent in radiotherapy-associated t-MDS, monosomy 7 was more common in t-AML and t-MDS after treatment with alkylators, and t(11q23) in t-AML was associated with topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_assertion evidence source_evidence_literature NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_assertion SIO_000772 12454741 NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_assertion wasDerivedFrom befree-2016 NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_assertion wasGeneratedBy ECO_0000203 NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.
- befree-2016 importedOn "2016-02-19" NP375872.RA6D9jBH32O_WVNCBtA1hhzkKmrxOg07_4qb15ESPr4_g130_provenance.